Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esreboxetine in Fibromyalgia
NCT00612170Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2007
- Primary completion
- May 2009
- Countries
- 2
01
Overview
A Phase 3 trial of esreboxetine in fibromyalgia (FM), sponsored by Pfizer. Started Dec 2007; status: completed.
02
Drugs
esreboxetine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00612170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00612170.